Vitamin B12 Deficiency and Miscarriage Risk
Yes, vitamin B12 deficiency is associated with increased risk of miscarriage and recurrent pregnancy loss, and should be systematically evaluated and corrected in women with unexplained pregnancy losses.
The Evidence Linking B12 Deficiency to Miscarriage
Multiple studies demonstrate a clear association between low vitamin B12 levels and pregnancy loss. Women with recurrent miscarriages have significantly lower serum B12 concentrations compared to healthy pregnant controls (mean 197 vs. 300 pg/mL, p=0.004), with the lowest levels (172 pg/mL) observed in women with primary recurrent abortion 1. In logistic regression analysis, low serum vitamin B12 emerged as the only significant predictor of recurrent pregnancy loss 1.
A case report provides compelling evidence: a 38-year-old woman with four early pregnancy losses and B12 deficiency (<150 pg/mL) achieved successful pregnancy after parenteral B12 therapy normalized her homocysteine levels within 2 months 2. This demonstrates both the causal relationship and the reversibility with treatment.
The Mechanism: Homocysteine Connection
The link between B12 deficiency and miscarriage operates primarily through elevated homocysteine levels:
- B12 deficiency causes hyperhomocysteinemia, which is associated with placental vasculopathy and pregnancy loss 3
- Women with recurrent miscarriages show elevated homocysteine (8.3 vs. 7.1 μmol/L in controls) 1
- Higher homocysteine is the only independent predictive factor for miscarriage (OR = 0.596, p=0.001) 3
- A strong negative correlation exists between B12 and homocysteine levels specifically in women with recurrent pregnancy loss 4
Clinical Implications and Testing
When to suspect B12 deficiency in pregnancy loss:
- Unexplained recurrent miscarriage (≥2 losses)
- Vegan or vegetarian diet without supplementation
- History of malabsorption (celiac disease, gastric surgery)
- Metformin use
- Unexplained fatigue or anemia not responding to iron 5
Testing approach:
- Measure serum B12 systematically in all women with recurrent pregnancy loss 2
- B12 <180 ng/L (133 pmol/L) confirms deficiency 5
- Consider homocysteine measurement as functional marker
- Note: The 2024 NICE guideline specifically states their testing recommendations should NOT be applied to pregnant women, requiring separate consideration 5
Treatment Recommendations
For B12 deficiency with pregnancy loss history:
- Parenteral (intramuscular) B12 is preferred over oral supplementation in malabsorption cases 2, 6
- Use 1000 μg hydroxocobalamin intramuscularly for loading, then individualized maintenance (ranging from every 2 weeks to every 2 months based on symptom resolution) 6
- Oral supplementation (5-250 μg daily) may be sufficient only for dietary deficiency 7
- Treatment should begin before attempting conception in women with prior losses
- Monitor for symptom resolution rather than titrating based on serum B12 levels 6
Important Caveats
The evidence has limitations:
- Methylmalonic acid (a functional B12 marker) did not consistently correlate with pregnancy loss, suggesting the relationship may be more complex than simple functional deficiency 1
- Some studies show no difference in homocysteine between women with missed vs. spontaneous abortions 3
- The mechanism may involve the metabolically inactive B12 fraction (holohaptocorrin) rather than functional deficiency 1
Despite these nuances, the clinical evidence supports screening and treating B12 deficiency in women with recurrent pregnancy loss, as treatment is safe, inexpensive, and potentially prevents devastating outcomes 2, 8.
The 2024 Cochrane review notes that while B12 supplementation improves maternal B12 status, trials have not adequately evaluated effects on spontaneous abortion due to lack of standardized definitions and quantitative reporting 7. However, the observational evidence and biological plausibility are sufficiently strong to warrant clinical action.